Wikidata

(Q40600194)

English

Safety and efficacy of recombinant human alpha-galactosidase A replacement therapy in Fabry's disease

scientific article published on July 2001

In more languages

Statements

title
Safety and efficacy of recombinant human alpha-galactosidase A replacement therapy in Fabry's disease (English)
1 reference
stated in
Europe PubMed Central
PubMed ID
11439963
retrieved
21 September 2017
author name string
C M Eng
series ordinal
1
1 reference
stated in
Europe PubMed Central
PubMed ID
11439963
retrieved
21 September 2017
N Guffon
series ordinal
2
1 reference
stated in
Europe PubMed Central
PubMed ID
11439963
retrieved
21 September 2017
W R Wilcox
series ordinal
3
1 reference
stated in
Europe PubMed Central
PubMed ID
11439963
retrieved
21 September 2017
D P Germain
series ordinal
4
1 reference
stated in
Europe PubMed Central
PubMed ID
11439963
retrieved
21 September 2017
S Waldek
series ordinal
6
1 reference
stated in
Europe PubMed Central
PubMed ID
11439963
retrieved
21 September 2017
L Caplan
series ordinal
7
1 reference
stated in
Europe PubMed Central
PubMed ID
11439963
retrieved
21 September 2017
G E Linthorst
series ordinal
8
1 reference
stated in
Europe PubMed Central
PubMed ID
11439963
retrieved
21 September 2017
International Collaborative Fabry Disease Study Group
series ordinal
10
1 reference
stated in
Europe PubMed Central
PubMed ID
11439963
retrieved
21 September 2017
publication date
1 July 2001
1 reference
stated in
Europe PubMed Central
PubMed ID
11439963
retrieved
21 September 2017
page(s)
9-16
1 reference
stated in
Europe PubMed Central
PubMed ID
11439963
retrieved
21 September 2017

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    Retrieved from "https://www.wikidata.org/w/index.php?title=Q40600194&oldid=2101391019"